Boardroom Alpha
8-K primary document
HYPD · Current Report (Form 8-K) · Filed May 6, 2026

Hyperion Defi Inc8-K exhibit

tm2613722d1_ex5-1.htm

 

Exhibit 5.1

 

 

 

1271 Avenue of the Americas

New York, New York 10020-1401 

Tel: +1.212.906.1200 Fax: +1.212.751.4864 

www.lw.com

 

FIRM / AFFILIATE OFFICES

  Austin      Milan
  Beijing      Munich
  Boston      New York
  Brussels      Orange County
  Chicago      Paris
May 6, 2026 Dubai      Riyadh
  Düsseldorf      San Diego
  Frankfurt      San Francisco
  Hamburg      Seoul
  Hong Kong      Silicon Valley
  Houston      Singapore
Hyperion DeFi, Inc. London      Tel Aviv
3090 Nowitzki Way, Suite 300 Los Angeles      Tokyo
Dallas, Texas 75219 Madrid      Washington, D.C.

 

Re:Registration Statement on Form S-3 (No. 333-291570); up to 3,194,444 shares of Common Stock, par value $0.0001 per share

 

To the addressee set forth above:

 

We have acted as special counsel to Hyperion DeFi, Inc., a Delaware corporation (the “Company”), in connection with the offering of up to 3,194,444 shares (including up to 416,666 shares issuable upon the exercise of the underwriter’s option to purchase additional shares) of common stock of the Company, par value $0.0001 per share (the “Shares”). The offering of the Shares was made under a registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on November 17, 2025 (File No. 333-291570) (as so filed and as amended, the “Registration Statement”), a base prospectus dated December 9, 2025 included in the Registration Statement at the time it originally became effective (the “Base Prospectus”), a preliminary prospectus supplement dated May 5, 2026 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the “Preliminary Prospectus”) and a prospectus supplement dated May 5, 2026 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the “Prospectus”). The Shares are being sold pursuant to an underwriting agreement dated May 5, 2026 between the Company and Chardan Capital Markets, LLC, as underwriter (the “Underwriting Agreement”).

 

This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the Preliminary Prospectus or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares.

 

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the “DGCL”), and we express no opinion with respect to any other laws.

 

 

 

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the Underwriting Agreement, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company and the Shares will be validly issued, fully paid and nonassessable.

 

In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.

 

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Company’s Current Report on Form 8-K dated May 5, 2026 and to the reference to our firm in the Prospectus under the heading “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

 

Sincerely,

 

/s/ Latham & Watkins LLP

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer